ChemImage Corporation announced today the receipt of its 100th U.S. patent, number 7,692,776 for a chemical imaging explosives optical sensor that detects explosive compounds.
Over the past 16 years, ChemImage has invested substantial resources in building a robust patent portfolio which includes patents for chemical imaging instrumentation, image analysis, threat detection, forensics tools, pharmaceutical analysis, particle sizing, and biomedical diagnostics.
"Issuance of our 100th patent represents a significant milestone in ChemImage's development," said Dr. Patrick Treado, ChemImage Founder and Chief Technology Officer. "As a technology company that is addressing critical measurement needs across a variety of industries, we have secured substantial protection of our intellectual property that will assist in fostering partnerships with market leaders worldwide."
Mitochondria’s division of labor sheds light on how cancer cells survive harsh conditions